Gyroxin and its biological activity: effects on CNS basement membranes and endothelium and protease-activated receptors.
Gyroxin is a glycoprotein isolated from rattlesnake venom, with known thrombin-like serine protease properties and behavioral action in the CNS. The mechanism of the latter has eluded experimenters for three decades. In this paper about the in vitro chick retina we demonstrate an excitotoxic CNS action of Gyroxin by observing retinal Intrinsic Optical Signals (IOS). These show sudden dynamic changes in the intact tissue due to gyroxin action. The very fast kinetics of this response precludes deep tissue penetration by the protein, a mechanism of tissue response described here for the first time. At nanomolar concentrations, Gyroxin alters profoundly the optical profiles of retinal spreading depression waves (RSDs), suggesting modulation of ionic transport and metabolism. This effect is reversible in contrast with the acute cell lysis induced with gyroxin pulses at higher concentration. Because there may be more than one target of Gyroxine at the retinal inner limiting membrane, additional biochemical assays were performed to study a possible Na/K-ATPase blockade and PAR receptor activation. We conclude that the Gyroxin interaction with basement membranes of CNS and endothelium triggers conformational phase transitions at basement membranes, with multiple functional consequences.
Centro de Biotecnologia, Instituto de Pesquisas Energéticas e Nucleares IPEN/SP.
J A A
JA
da Silva
P
P
Spencer
M A
MA
Camillo
V M F
VM
de Lima
D000818:Animals; D001485:Basement Membrane / Q000187:drug effects / Q000378:metabolism; D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology; D001812:Blood-Brain Barrier / Q000187:drug effects / Q000378:metabolism; D016466:CHO Cells; D002470:Cell Survival / Q000187:drug effects; D002645:Chickens; D013181:Cortical Spreading Depression / Q000187:drug effects; D006224:Cricetinae; D003412:Cricetulus; D003435:Crotalid Venoms / Q000302:isolation & purification / Q000494:pharmacology*; D004727:Endothelium / Q000187:drug effects* / Q000502:physiology; D061307:Human Umbilical Vein Endothelial Cells / Q000166:cytology / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D051379:Mice; D009498:Neurotoxins / Q000494:pharmacology; D044463:Receptor, PAR-1 / Q000378:metabolism; D012160:Retina / Q000187:drug effects / Q000502:physiology; D014688:Venoms / Q000737:chemistry; D010975:Platelet Aggregation Inhibitors
D003435:Crotalid Venoms; D009498:Neurotoxins; D044463:Receptor, PAR-1; D014688:Venoms; C017356:gyroxin; D010975:Platelet Aggregation Inhibitors